A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.

NCT00249782 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Rosacea

Interventions

DRUG: Vehicle control, 2x/day
DRUG: ACZONE (dapsone) Gel, 5%, 2x/day
DRUG: ACZONE (dapsone) Gel, 5%, 1x/day
DRUG: MetroGel® (metronidazole gel), 1.0% 1x/day
DRUG: ACZONE (dapsone) Gel, 5%, 1x/day (AM) + MetroGel (metronidazole gel), 1.0%, 1x/day (PM)

Sponsor

Allergan